We work with life sciences organizations operating across Japan and global markets, focusing on the points where science, strategy, and execution need to align to move programs forward.
Cross-Border Strategy & Positioning
Aligning development strategies across Japan and global markets, taking into account regulatory, clinical, and partnering realities in both directions
Positioning assets for expansion into Japan or global markets
Defining cross-border development and partnership pathways
Business Development & Partnering
Identifying and advancing partnerships between Japanese and international biotechs, pharmaceutical companies, and stakeholders
Structuring collaborations, licensing opportunities, and strategic alliances across borders
Supporting negotiations through to aligned outcomes
Investor & Capital Interface
Positioning programs for investment across Japanese and global investor networks
Supporting diligence and evaluation processes
Bridging communication between companies and investors across geographies
Program & Development Execution
Positioning programs for investment across Japanese and global investor networks
Supporting diligence and evaluation processes
Bridging communication between companies and investors across geographies
Advising leadership teams at key cross-border decision points
Aligning stakeholders across companies, investors, and academic groups in Japan and globally
Ensuring clarity, alignment, and forward momentum in complex, multi-regional settings